Every great new discovery is built on a mountain of data. But that data tends to reside within many different sources:
- internal databases built on platforms that might not integrate
- various documents and tools
- external public databases.
That makes data retrieval and analysis particularly challenging, and limits the ability to leverage cutting-edge tools like machine learning and AI algorithms for next-gen analytics.
Making better connections with BioTech360
Biotechnology and pharmaceutical companies today are playing with one hand tied behind their backs. Analytical tools like high-throughput screens produce volumes of valuable data that, too often, sits in hard-to-access databases. Lab tools continue to generate new data that must be linked to existing data retrospectively. And sequencing data – whether produced in-house or made available through public databases – are disconnected from this experimental data altogether.
BioTech360 was designed to empower better decision-making by bringing new data, old data, and external data together, raising the bar for the kinds of insights possible from complex systems. It is an end-to-end scientific knowledge management platform that can standardize, integrate, and analyze data, while connecting to automated workflows and enabling bioinformatics tools.
To make all the data accessible, BioTech360 uses semantic technology to ensure connectivity and simplify visualization. It integrates with LabVantage Laboratory Information Management Systems (LIMS), centralizing sequencing data for R&D teams and enriching it through connections with external databases. Manufacturing teams can then seamlessly access R&D insights that can help with process optimization.
The information available for analytics today is just a fraction of what will be available tomorrow. BioTech360 is designed for scalability, growing with your organization and your new inputs. In addition, data is structured by Findable, Accessible, Interoperable, and Reusable (FAIR) principles that improve transparency and reproducibility today, and underpin potential AI applications just around the corner.
Expanding what’s possible across life sciences
LabVantage Biomax’s BioTech360 is built with specialized apps for a range of research areas, as well as unique capabilities to make genomics data more accessible.
Oncology, Immunology, and Infectious Diseases:
- Massive amounts of high-throughput screening and sequencing data need to be quickly retrievable in order to improve antibody and nanobody research. BioTech360 can do this while integrating with more than 70 public databases, making it easier to cross-reference relevant sequence details and visualize 3D structures.
Molecular Biology, Microbiology, Synthetic Biology:
- For research areas that rely on plasmids, BioTech360 enables importation, management, and annotation of plasmid sequences used to study the expression of genes and protein functions, and develop to gene therapies. Annotating sequences and connecting with external databases and bioinformatics tools make data credibility crucial, and BioTech360 includes automatic checks and enforced metadata standards.
Genomics:
- Data from eukaryotic, prokaryotic, and viral genomes are searchable by genes, proteins, and genomes with BioTech360. Integration with external databases and bioinformatics tools help enrich information and make detailed reporting simpler.
Better, faster decisions
The measure of a data integration tool is whether it increases the actionability of data to improve decision-making – and BioTech360 excels. Beyond meaningful data integration, BioTech360 empowers analytics and AI throughout biopharma R&D to shrink the time from discovery to market.
Contact us today to learn more about how BioTech360 can empower your data decision making.